Agios Pharmaceuticals | AGIO - Trade Debtors


Agios Pharmaceuticals reported $10.58M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Agios Pharmaceuticals USD 10.58M 5.55M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Astellas Pharma JPY 810.23B 75.43B Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Bayer EUR 14.19B 720M Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Daiichi Sankyo JPY 695.95B 79.1B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Exelixis USD 286.92M 24.38M Dec/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Incyte USD 1.02B 128.52M Dec/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
Merck USD 12.12B 596M Sep/2025
Moderna USD 184M 862M Dec/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sarepta Therapeutics USD 398.23M 2.49M Dec/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025